{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T02:41:04Z","timestamp":1789094464133,"version":"build-2803163510"},"reference-count":32,"publisher":"American Society for Microbiology","issue":"3","license":[{"start":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T00:00:00Z","timestamp":1613520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2021,2,17]]},"abstract":"<jats:p>\n            Due to the increase of antifungal drug resistance and difficulties associated with drug administration, new antifungal agents for invasive fungal infections are needed. SCY-247 is a second-generation fungerp antifungal compound that interferes with the synthesis of the fungal cell wall polymer \u03b2-(1,3)-\n            <jats:sc>d<\/jats:sc>\n            -glucan.\n          <\/jats:p>","DOI":"10.1128\/aac.01988-20","type":"journal-article","created":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T13:27:58Z","timestamp":1607606878000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":17,"title":["A Second-Generation Fungerp Analog, SCY-247, Shows Potent\n            <i>In Vitro<\/i>\n            Activity against Candida auris and Other Clinically Relevant Fungal Isolates"],"prefix":"10.1128","volume":"65","author":[{"given":"Sherman","family":"Chu","sequence":"first","affiliation":[{"name":"Department of Dermatology, Case Western Reserve University, Cleveland, Ohio, USA"},{"name":"College of Osteopathic Medicine of the Pacific-Northwest (COMP), Lebanon, Oregon, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Long","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Case Western Reserve University, Cleveland, Ohio, USA"},{"name":"Center for Medical Mycology, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rania","family":"Sherif","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Case Western Reserve University, Cleveland, Ohio, USA"},{"name":"Center for Medical Mycology, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas S.","family":"McCormick","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Case Western Reserve University, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katyna","family":"Borroto-Esoda","sequence":"additional","affiliation":[{"name":"Scynexis Inc., Jersey City, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Barat","sequence":"additional","affiliation":[{"name":"Scynexis Inc., Jersey City, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8833-7323","authenticated-orcid":true,"given":"Mahmoud A.","family":"Ghannoum","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Case Western Reserve University, Cleveland, Ohio, USA"},{"name":"Center for Medical Mycology, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14472-8"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mmcr.2016.04.005"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.12.5157-5159.2005"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.06112-11"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02145-13"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00238-18"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1179\/joc.2011.23.6.319"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00029-06"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2008.01978.x"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1086\/651262"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1086\/375822"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1080\/00015550410024553"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.46548-0"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-199905000-00020"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.5173\/ceju.2015.01.474"},{"key":"e_1_3_2_17_2","unstructured":"Scynexis Inc. 2020. Phase 3 study of oral ibrexafungerp (SCY-078) vs. placebo in subjects with recurrent vulvovaginal candidiasis (VVC) (CANDLE). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04029116?term=scynexis&draw=2."},{"key":"e_1_3_2_18_2","volume-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard\u2014third edition. CLSI document M27-A3.","author":"Clinical and Laboratory Standard Institute.","year":"2008","unstructured":"Clinical and Laboratory Standard Institute. 2008. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard\u2014third edition. CLSI document M27-A3. Clinical and Laboratory Standard Institute, Wayne, PA."},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1086\/595846"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1086\/510592"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.44.3.760-763.2006"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00111-06"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00485-06"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/aac.46.9.3001-3012.2002"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01588-12"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00161-17"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00244-18"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02396-16"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01961-16"},{"key":"e_1_3_2_30_2","unstructured":"Borroto-Esoda K Scorneaux B Helou F Angulo D. 2017. In vitro interaction between SCY-078 echinocandins and azoles against susceptible & resistant Candida spp. determined by the checkerboard method. ASM Microbe 2017 New Orleans LA."},{"key":"e_1_3_2_31_2","volume-title":"Reference method for broth dilution antifungal susceptibility testing of filamentous fungi.","author":"Rex J","year":"2008","unstructured":"Rex J, Alexander B, Andes D, Arthington-Skaggs B, Brown S, Chaturveil V. 2008. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard\u2014second edition. Clinical and Laboratory Standards Institute, Wayne PA."},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.36.10.2874-2876.1998"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1097\/IPC.0b013e318059b94b"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01988-20","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01988-20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T21:48:41Z","timestamp":1645480121000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.01988-20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,17]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,2,17]]}},"alternative-id":["10.1128\/AAC.01988-20"],"URL":"https:\/\/doi.org\/10.1128\/aac.01988-20","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,17]]},"assertion":[{"value":"2020-09-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-12","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-17","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e01988-20"}}